4
Changes in Ownership
NewAmsterdam Pharma Co N.V. Filed Acc 0000950170-25-074463
Chief Operating Officer sold 100,000 shares
- Chief Operating Officer acquired 100,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Kling Douglas F · Chief Operating Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-05-15 | Exercise or conversion : show line 1 in the form 10b5-1 | +100,000 | $10.00 | $1,000,000 | 144,000 | D |
| 2025-05-15 | Sale : show line 2 in the form 10b5-1 | −100,000 | 44,000 | D | ||
| Open-market sales · 100,000 sh | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-05-15 | Exercise or conversion : show line 3 in the form 10b5-1 Option (right to buy) | −100,000 | 450,930 | D |
Loading xslF345X05/ownership.xml…